Holen Sie sich die Stockscreener-App
22.77
1.74%
0.39
Handel nachbörslich:
22.82
0.05
+0.22%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BAX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$22.38
Offen:
$22.35
24-Stunden-Volumen:
6.03M
Relative Volume:
0.84
Marktkapitalisierung:
$11.70B
Einnahmen:
$11.89B
Nettoeinkommen (Verlust:
$-560.00M
KGV:
-20.70
EPS:
-1.1
Netto-Cashflow:
$191.00M
1W Leistung:
-0.39%
1M Leistung:
-7.78%
6M Leistung:
-33.48%
1J Leistung:
-40.03%
1-Tages-Spanne:
$22.08
$22.86
1-Wochen-Bereich:
$21.59
$22.91
52-Wochen-Spanne:
$21.33
$38.28
Baxter International Inc Stock (BAX) Company Profile
Firmenname
Baxter International Inc
Sektor
Telefon
(224) 948-2000
Adresse
ONE BAXTER PARKWAY, DEERFIELD, IL
Vergleichen Sie BAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
22.77 | 11.49B | 11.89B | -560.00M | 191.00M | -1.10 |
|
ISRG
Intuitive Surgical Inc
|
447.23 | 157.45B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
187.17 | 52.74B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
273.73 | 39.69B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
74.51 | 36.64B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
262.33 | 18.72B | 2.96B | 487.70M | 344.00M | 6.68 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-04 | Herabstufung | Stifel | Buy → Hold |
| 2025-08-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-02-26 | Fortgesetzt | Goldman | Buy |
| 2025-02-24 | Hochstufung | Argus | Hold → Buy |
| 2025-02-20 | Fortgesetzt | Barclays | Overweight |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-06-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Goldman | Neutral → Sell |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-18 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-18 | Bestätigt | Raymond James | Outperform |
| 2022-02-18 | Bestätigt | Stifel | Buy |
| 2022-02-18 | Bestätigt | UBS | Neutral |
| 2022-02-18 | Bestätigt | Wells Fargo | Overweight |
| 2022-02-11 | Eingeleitet | Goldman | Neutral |
| 2022-01-07 | Fortgesetzt | Citigroup | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-09-03 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Herabstufung | UBS | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-09-04 | Herabstufung | Argus | Buy → Hold |
| 2020-06-24 | Eingeleitet | Oppenheimer | Outperform |
| 2020-03-19 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-02 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Hochstufung | Argus | Hold → Buy |
| 2018-10-16 | Eingeleitet | Barclays | Underweight |
| 2018-05-17 | Fortgesetzt | Piper Jaffray | Overweight |
| 2018-02-06 | Bestätigt | Citigroup | Neutral |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2018-01-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
Alle ansehen
Baxter International Inc Aktie (BAX) Neueste Nachrichten
Baxter names new Senior VP and Chief Accounting Officer - MSN
Will Baxter International Inc. stock beat Nasdaq index returnsEarnings Overview Summary & Long-Term Safe Investment Plans - newser.com
How Baxter International Inc. stock performs during market turbulenceMarket Weekly Review & Low Drawdown Trading Techniques - newser.com
Is Baxter International Inc. stock a buy on weaknessEarnings Performance Report & Risk Controlled Stock Pick Alerts - newser.com
Is Baxter International Inc BTL a good long term investmentEquity Performance Review & Rapid Capital Gain - earlytimes.in
Baxter International: Medical Business In Need Of A Save Itself (NYSE:BAX) - Seeking Alpha
Advanced analytics toolkit walkthrough for Baxter International Inc.Market Growth Summary & Precise Swing Trade Alerts - newser.com
Detecting price anomalies in Baxter International Inc. with AITrade Entry Summary & High Yield Equity Trading Tips - newser.com
Baxter International Inc. (BAX) Stock Analysis: Navigating a 30% Potential Upside Amidst Industry Challenges - DirectorsTalk Interviews
Measuring Baxter International Inc.’s beta against major indicesJuly 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com
Precision Trading with Baxter International Inc. (BAX) Risk Zones - news.stocktradersdaily.com
Can Baxter International Inc. (BTL) stock sustain free cash flowMarket Movers & Consistent Growth Equity Picks - newser.com
Will Baxter International Inc. stock benefit from Fed rate cutsJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - newser.com
Should FDA Clearance and Supply Chain Risks Drive a Reassessment of Baxter International’s (BAX) Digital Health Strategy? - simplywall.st
Baxter International (BAX): Valuation Check After U.S. National Security Probe Rattles Medical Device Sector - Yahoo Finance
I'm the former CEO of a $12 billion health care company and I serve on many boards. AI deserves a seat at the table - Fortune
How Baxter International Inc. (BAX) Affects Rotational Strategy Timing - news.stocktradersdaily.com
U.S. Home Healthcare Market Size, Share & Trends Analysis Report 2025-2033: Focus on Neurological & Mental Disorders, Diabetes & Kidney Disorders, Cancer, Wound Care - GlobeNewswire Inc.
Baxter earns gold level resiliency badge for critical medical supplies - Investing.com India
Baxter earns gold level resiliency badge for critical medical supplies By Investing.com - Investing.com Canada
Baxter is First Manufacturer to Achieve Gold Resiliency Badge for IV Solutions, Nutrition Solutions and Premix Drugs from Healthcare Industry Resilience Collaborative (HIRC) - The Joplin Globe
Baxter International Inc. Stock Slides 3.8%, Underperforms Peers - 富途牛牛
Trump Administration Review Targets Medical Supply ChainBecton Dickinson (NYSE:BDX), Baxter Intl (NYSE:BAX) - Benzinga
Why Baxter (BAX) Stock Is Trading Lower Today - FinancialContent
Regenerative Drugs Market Review 2020-2024 and Forecast - GlobeNewswire
Baxter, GE HealthCare shares fall after US launches medical device probe By Investing.com - Investing.com South Africa
Baxter, GE HealthCare shares fall after US launches medical device probe - Investing.com Australia
Regenerative Drugs Market Review 2020-2024 and Forecast 2025-2030: A $29 Billion Opportunity Led by Baxter International, Stryker Corporation and Medtronic - Yahoo Finance
Regenerative Medicine Industry Trends and Growth - GlobeNewswire
Regenerative Medicine Industry Trends and Growth Strategies, 2025-2030 Featuring Novartis, Biogen, GlaxoSmithKline, Baxter International, and Boehringer Ingelheim - Yahoo Finance
Baxter workers rebuild lives, reestablish IV bag supply after Hurricane Helene - WCNC
Parenteral Formula Market Is Going to Boom | Major Giants Baxter International, Fresenius Kabi, B. Braun, Grifols - openPR.com
Baxter International Inc. (NYSE:BAX) Receives $30.11 Consensus Price Target from Analysts - MarketBeat
Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring - biomb.ca
Baxter to split into two companies - The Covington News
Jim Cramer on Baxter: “They Are the King of Disappointment” - MSN
Fiduciary Alliance LLC Takes $1.91 Million Position in Baxter International Inc. $BAX - MarketBeat
Will BAX's Q1 Earnings Improve Following Transformation Completion? - MSN
Baxter International’s Valuation in Focus After FDA-Cleared Vital Signs Monitor Launch - simplywall.st
Rep. Lisa C. McClain Sells Off Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
AG2R LA Mondiale Gestion D Actifs Invests $1.02 Million in Baxter International Inc. $BAX - MarketBeat
Is Baxter International Stock Underperforming The Dow? - Barchart.com
CEO Change: Does Baxter International Inc. outperform in volatile marketsTrade Entry Report & Capital Efficiency Focused Strategies - خودرو بانک
Baxter International Inc. $BAX Position Boosted by Park National Corp OH - MarketBeat
Aug Sentiment: How does Baxter International Inc. score in quality rankingsMarket Activity Report & Weekly Watchlist of Top Performers - خودرو بانک
Finanzdaten der Baxter International Inc-Aktie (BAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):